Deregulation of IL-6 expression and JAK/STAT pathway most likely contribute to the development and progression of CTCL; however, the exact mechanism is still not fully understood. The gene discussed is IL6; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.